Key Compliance Statements
The company confirms its awareness of responsibility to disseminate price-sensitive information to stock exchanges. It states it has been promptly disclosing events or information required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Specific Confirmations
Astec LifeSciences confirms:
- Full compliance with disclosure requirements under the Listing Regulations
- No developments have occurred requiring mandatory disclosure under either the Listing Regulations or the SEBI (Prohibition of Insider Trading) Regulations, 2015
- Commitment to continue full compliance with disclosure obligations as required
Financial Impact
No specific financial impact or quantitative figures are disclosed in this compliance communication.